Hodgson Ian
Chief Operating Officer
Hodgson Ian has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Feb 18, 2026.
On the most recent filing, Hodgson Ian is listed as Chief Operating Officer at Corbus Pharmaceuticals Holdings, Inc. Inside the rolling window, Hodgson Ian reported no open-market purchases and 2 open-market sales totaling $26K in CRBP. The largest disclosed transaction in the window is a sale of 2,415 CRBP shares on Feb 3, 2026, worth $20K.
Companies traded
Other insiders at CRBP
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$26K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Hodgson Ian made?
Hodgson Ian has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Hodgson Ian trade?
Hodgson Ian has filed SEC Form 4 disclosures for 1 company, including CRBP.
When was Hodgson Ian's most recent SEC Form 4 filing?
Hodgson Ian's most recent SEC Form 4 filing on Tracefour is dated Feb 18, 2026.
What is Hodgson Ian's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Hodgson Ian is listed as Chief Operating Officer.
What is Hodgson Ian's total buy and sell value in the current window?
Inside the rolling retention window, Hodgson Ian bought $0 and sold $26K based on SEC Form 4 filings.
What was Hodgson Ian's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,415 CRBP shares on 2026-02-03, worth $20K, per SEC Form 4 filings.